{"transactions":[{"id":800114,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant (right to buy)","published_at":"2026-04-27T21:27:00.000Z","date":"2026-04-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":827586,"price":21.4999,"value":17793016.2414,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 9, 2026, AI Day1 tendered all of its shares of Common Stock pursuant to the tender offer by Servier Detroit Inc. (\"Purchaser\") to purchase all of the issued and outstanding shares of Common Stock for $21.50 per share in cash, upon the terms and subject to the conditions described in the Offer to Purchase and related Letter of Transmittal filed with the SEC on Schedule TO on March 26, 2026. Such shares were accepted by the Purchaser on April 23, 2026. On April 23, 2026, in connection with the consummation of the merger, each pre-funded warrant held by AI Day1 to purchase Common Stock was converted into the right to receive $21.4999 per warrant in cash."},{"field":"shares","element":"transactionShares","label":"F1","text":"On April 9, 2026, AI Day1 tendered all of its shares of Common Stock pursuant to the tender offer by Servier Detroit Inc. (\"Purchaser\") to purchase all of the issued and outstanding shares of Common Stock for $21.50 per share in cash, upon the terms and subject to the conditions described in the Offer to Purchase and related Letter of Transmittal filed with the SEC on Schedule TO on March 26, 2026. Such shares were accepted by the Purchaser on April 23, 2026. On April 23, 2026, in connection with the consummation of the merger, each pre-funded warrant held by AI Day1 to purchase Common Stock was converted into the right to receive $21.4999 per warrant in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each pre-funded warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire. The pre-funded warrants are not exercisable to the extent that the aggregate number of shares of Common Stock beneficially owned by AI Day1 LLC, including together with its direct or indirect affiliates, any person acting or who could be deemed to be acting as a group together with the holder, and any other persons whose beneficial ownership of the Common Stock would or could be aggregated with the holder's for the purposes of Section 13(d) or Section 16 of the Exchange Act of 1934, as amended, immediately following such exercise would exceed 9.99%; provided, however, that AI Day1 LLC may increase or decrease the beneficial ownership limitation by giving 61 days' notice to the Issuer, but not to exceed any percentage in excess of 19.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each pre-funded warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire. The pre-funded warrants are not exercisable to the extent that the aggregate number of shares of Common Stock beneficially owned by AI Day1 LLC, including together with its direct or indirect affiliates, any person acting or who could be deemed to be acting as a group together with the holder, and any other persons whose beneficial ownership of the Common Stock would or could be aggregated with the holder's for the purposes of Section 13(d) or Section 16 of the Exchange Act of 1934, as amended, immediately following such exercise would exceed 9.99%; provided, however, that AI Day1 LLC may increase or decrease the beneficial ownership limitation by giving 61 days' notice to the Issuer, but not to exceed any percentage in excess of 19.99%."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Day1 LLC (\"AI Day1\") and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AI Day1. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":0,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":827586},"source":{"system":"sec-edgar","filing":"0001193125-26-182440","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000119312526182440/ownership.xml","form_type":"4"}},{"id":800113,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-27T21:27:00.000Z","date":"2026-04-23","kind":"other","planned":false,"acquired":false,"shares":12929322,"price":21.5,"value":277980423.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 9, 2026, AI Day1 tendered all of its shares of Common Stock pursuant to the tender offer by Servier Detroit Inc. (\"Purchaser\") to purchase all of the issued and outstanding shares of Common Stock for $21.50 per share in cash, upon the terms and subject to the conditions described in the Offer to Purchase and related Letter of Transmittal filed with the SEC on Schedule TO on March 26, 2026. Such shares were accepted by the Purchaser on April 23, 2026. On April 23, 2026, in connection with the consummation of the merger, each pre-funded warrant held by AI Day1 to purchase Common Stock was converted into the right to receive $21.4999 per warrant in cash."},{"field":"shares","element":"transactionShares","label":"F1","text":"On April 9, 2026, AI Day1 tendered all of its shares of Common Stock pursuant to the tender offer by Servier Detroit Inc. (\"Purchaser\") to purchase all of the issued and outstanding shares of Common Stock for $21.50 per share in cash, upon the terms and subject to the conditions described in the Offer to Purchase and related Letter of Transmittal filed with the SEC on Schedule TO on March 26, 2026. Such shares were accepted by the Purchaser on April 23, 2026. On April 23, 2026, in connection with the consummation of the merger, each pre-funded warrant held by AI Day1 to purchase Common Stock was converted into the right to receive $21.4999 per warrant in cash."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Day1 LLC (\"AI Day1\") and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AI Day1. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-182440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000119312526182440/ownership.xml","form_type":"4"}},{"id":1440967,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}}],"security":"Warrant (right to buy)","published_at":"2024-08-05T20:01:10.000Z","date":"2024-08-01","kind":"purchase","planned":false,"acquired":true,"shares":827586,"price":14.4999,"value":11999914.2414,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each pre-funded warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire. The pre-funded warrants are not exercisable to the extent that the aggregate number of shares of Common Stock beneficially owned by AI Day1 LLC, including together with its direct or indirect affiliates, any person acting or who could be deemed to be acting as a group together with the holder, and any other persons whose beneficial ownership of the Common Stock would or could be aggregated with the holder's for the purposes of Section 13(d) or Section 16 of the Exchange Act of 1934, as amended, immediately following such exercise would exceed 9.99%; provided, however, that AI Day1 LLC may increase or decrease the beneficial ownership limitation by giving 61 days' notice to the Issuer, but not to exceed any percentage in excess of 19.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each pre-funded warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire. The pre-funded warrants are not exercisable to the extent that the aggregate number of shares of Common Stock beneficially owned by AI Day1 LLC, including together with its direct or indirect affiliates, any person acting or who could be deemed to be acting as a group together with the holder, and any other persons whose beneficial ownership of the Common Stock would or could be aggregated with the holder's for the purposes of Section 13(d) or Section 16 of the Exchange Act of 1934, as amended, immediately following such exercise would exceed 9.99%; provided, however, that AI Day1 LLC may increase or decrease the beneficial ownership limitation by giving 61 days' notice to the Issuer, but not to exceed any percentage in excess of 19.99%."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Day1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and controls a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":827586,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":827586},"source":{"system":"sec-edgar","filing":"0000950170-24-090703","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000095017024090703/ownership.xml","form_type":"4"}},{"id":1756996,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}}],"security":"Common Stock","published_at":"2023-10-20T20:02:31.000Z","date":"2023-10-20","kind":"purchase","planned":false,"acquired":true,"shares":111387,"price":9.9734,"value":1110907.1058,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average purchase price of the shares of common stock. The shares of common stock were purchased in multiple transactions ranging from $9.83 to $10.13 inclusive. The reporting persons undertake to provide to Day One Biopharmaceuticals, Inc., any security holder of Day One Biopharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Day1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and controls a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":12929322,"source":{"system":"sec-edgar","filing":"0001209191-23-053235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000120919123053235/doc4.xml","form_type":"4"}},{"id":1756995,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}}],"security":"Common Stock","published_at":"2023-10-20T20:02:31.000Z","date":"2023-10-19","kind":"purchase","planned":false,"acquired":true,"shares":384400,"price":10.0608,"value":3867371.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average purchase price of the shares of common stock. The shares of common stock were purchased in multiple transactions ranging from $9.88 to $10.20 inclusive. The reporting persons undertake to provide to Day One Biopharmaceuticals, Inc., any security holder of Day One Biopharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Day1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and controls a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":12817935,"source":{"system":"sec-edgar","filing":"0001209191-23-053235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000120919123053235/doc4.xml","form_type":"4"}},{"id":1756994,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}}],"security":"Common Stock","published_at":"2023-10-20T20:02:31.000Z","date":"2023-10-18","kind":"purchase","planned":false,"acquired":true,"shares":979667,"price":10.2076,"value":10000048.8692,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price of the shares of common stock. The shares of common stock were purchased in multiple transactions ranging from $10.07 to $10.29 inclusive. The reporting persons undertake to provide to Day One Biopharmaceuticals, Inc., any security holder of Day One Biopharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Day1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and controls a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":12433535,"source":{"system":"sec-edgar","filing":"0001209191-23-053235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000120919123053235/doc4.xml","form_type":"4"}},{"id":1859043,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}}],"security":"Common Stock","published_at":"2023-06-12T20:03:36.000Z","date":"2023-06-09","kind":"purchase","planned":false,"acquired":true,"shares":769230,"price":13,"value":9999990.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported are held directly by AI Day1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and controls a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":11453868,"source":{"system":"sec-edgar","filing":"0001209191-23-036242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000120919123036242/doc4.xml","form_type":"4"}},{"id":2225707,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}}],"security":"Common Stock","published_at":"2022-06-21T20:37:06.000Z","date":"2022-06-17","kind":"purchase","acquired":true,"shares":1200000,"price":15,"value":18000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents securities purchased in the Issuer's public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Day1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and controls a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":10684638,"source":{"system":"sec-edgar","filing":"0001209191-22-038431","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000120919122038431/doc4.xml","form_type":"4"}},{"id":2430884,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}}],"security":"Common Stock","published_at":"2022-01-20T23:37:53.000Z","date":"2022-01-20","kind":"purchase","acquired":true,"shares":4615,"price":14.7293,"value":67975.7195,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.60 to $14.75, inclusive. The reporting person undertakes to provide to Day One Biopharmaceuticals, Inc., any security holder of Day One Biopharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Day 1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":9484638,"source":{"system":"sec-edgar","filing":"0001209191-22-004174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000120919122004174/doc4.xml","form_type":"4"}},{"id":2430883,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}}],"security":"Common Stock","published_at":"2022-01-20T23:37:53.000Z","date":"2022-01-19","kind":"purchase","acquired":true,"shares":58818,"price":14.699,"value":864565.782,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.16 to $14.75, inclusive. The reporting person undertakes to provide to Day One Biopharmaceuticals, Inc., any security holder of Day One Biopharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Day 1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":9480023,"source":{"system":"sec-edgar","filing":"0001209191-22-004174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000120919122004174/doc4.xml","form_type":"4"}},{"id":2430882,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}}],"security":"Common Stock","published_at":"2022-01-20T23:37:53.000Z","date":"2022-01-18","kind":"purchase","acquired":true,"shares":43429,"price":14.2616,"value":619367.0264,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.05 to $14.53, inclusive. The reporting person undertakes to provide to Day One Biopharmaceuticals, Inc., any security holder of Day One Biopharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Day 1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":9421205,"source":{"system":"sec-edgar","filing":"0001209191-22-004174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000120919122004174/doc4.xml","form_type":"4"}},{"id":2683713,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day 1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}}],"security":"Series B Redeemable Convertible Preferred Stock","published_at":"2021-06-03T20:42:50.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":741396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of common stock of the Issuer immediately prior to the completion of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of common stock of the Issuer immediately prior to the completion of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of common stock of the Issuer immediately prior to the completion of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported are held directly by AI Day 1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":741396},"source":{"system":"sec-edgar","filing":"0001209191-21-037697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000120919121037697/doc4.xml","form_type":"4"}},{"id":2683712,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day 1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}}],"security":"Series A Redeemable Convertible Preferred Stock","published_at":"2021-06-03T20:42:50.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":7761380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Redeemable Convertible Preferred Stock automatically converted into one share of common stock of Day One Biopharmaceuticals, Inc. (the \"Issuer\") immediately prior to the completion of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Redeemable Convertible Preferred Stock automatically converted into one share of common stock of Day One Biopharmaceuticals, Inc. (the \"Issuer\") immediately prior to the completion of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Redeemable Convertible Preferred Stock automatically converted into one share of common stock of Day One Biopharmaceuticals, Inc. (the \"Issuer\") immediately prior to the completion of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported are held directly by AI Day 1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7761380},"source":{"system":"sec-edgar","filing":"0001209191-21-037697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000120919121037697/doc4.xml","form_type":"4"}},{"id":2683711,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day 1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}}],"security":"Common Stock","published_at":"2021-06-03T20:42:50.000Z","date":"2021-06-01","kind":"purchase","acquired":true,"shares":875000,"price":16,"value":14000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents securities purchased in the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported are held directly by AI Day 1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":9377776,"source":{"system":"sec-edgar","filing":"0001209191-21-037697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000120919121037697/doc4.xml","form_type":"4"}},{"id":2683710,"issuer":{"id":51180,"kind":"organization","name":"Day One Biopharmaceuticals, Inc.","symbol":"DAWN"},"owners":[{"id":51181,"kind":"organization","name":"AI Day1 LLC","position":1,"cik":"0001863302","reported_name":"AI Day 1 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of 10% Owner"}}],"security":"Common Stock","published_at":"2021-06-03T20:42:50.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":8502776,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Redeemable Convertible Preferred Stock automatically converted into one share of common stock of Day One Biopharmaceuticals, Inc. (the \"Issuer\") immediately prior to the completion of the Issuer's initial public offering and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of common stock of the Issuer immediately prior to the completion of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported are held directly by AI Day 1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":8502776,"source":{"system":"sec-edgar","filing":"0001209191-21-037697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863302/000120919121037697/doc4.xml","form_type":"4"}}]}